Show simple item record

dc.contributor.authorDhaliwal, B
dc.contributor.authorPang, MOY
dc.contributor.authorKeeble, AH
dc.contributor.authorJames, LK
dc.contributor.authorGould, HJ
dc.contributor.authorMcDonnell, JM
dc.contributor.authorSutton, BJ
dc.contributor.authorBeavil, AJ
dc.date.accessioned2019-03-12T14:37:21Z
dc.date.available2017-03-17
dc.date.available2019-03-12T14:37:21Z
dc.date.issued2017-03-31
dc.identifier.citationDhaliwal, B. et al. IgE binds asymmetrically to its B cell receptor CD23. Sci. Rep. 7, 45533; doi: 10.1038/srep45533 (2017).en_US
dc.identifier.issn2045-2322
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/56107
dc.description.abstractThe antibody IgE plays a central role in allergic disease mechanisms. Its effector functions are controlled through interactions between the Fc region and two principal cell surface receptors FcεRI and CD23. The interaction with FcεRI is primarily responsible for allergic sensitization and the inflammatory response, while IgE binding to CD23 is involved in the regulation of IgE synthesis and allergen transcytosis. Here we present the crystal structure of a CD23/IgE-Fc complex and conduct isothermal titration calorimetric binding studies. Two lectin-like "head" domains of CD23 bind to IgE-Fc with affinities that differ by more than an order of magnitude, but the crystal structure reveals only one head bound to one of the two identical heavy-chains in the asymmetrically bent IgE-Fc. These results highlight the subtle interplay between receptor binding sites in IgE-Fc and their affinities, the understanding of which may be exploited for therapeutic intervention in allergic disease.en_US
dc.format.extent45533
dc.languageeng
dc.language.isoenen_US
dc.publisherNature Research (part of Springer Nature)en_US
dc.relation.ispartofSci Rep
dc.rightsThis work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectAllergensen_US
dc.subjectB-Lymphocytesen_US
dc.subjectBinding Sitesen_US
dc.subjectHumansen_US
dc.subjectImmunoglobulin Een_US
dc.subjectImmunoglobulin Fc Fragmentsen_US
dc.subjectProtein Bindingen_US
dc.subjectReceptors, IgEen_US
dc.subjectTranscytosisen_US
dc.titleIgE binds asymmetrically to its B cell receptor CD23.en_US
dc.typeArticleen_US
dc.rights.holder© The Author(s) 2017
dc.identifier.doi10.1038/srep45533
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/28361904en_US
pubs.notesNo embargoen_US
pubs.publication-statusPublished onlineen_US
pubs.publisher-urlhttps://doi.org/10.1038/srep45533
pubs.volume7en_US
dcterms.dateAccepted2017-02-21
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/